Text size

UBS WM launches impact investing venture

UBS Wealth Management (WM) makes strides in impact investing through its recent collaboration to push development for cancer cures. The Swiss private bank announced that it will work with MPM Capital, a bioventure investment firm, to help with academic research and better access to cancer care in the developing world. The drive spotlights impact investing – a nascent but increasingly…

To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].

Have a confidential tip? Get in touch [email protected]